VOCO Introduces Provicol QM Aesthetic Temporary Cement

Article

New temporary cement is designed to provide optimal esthetics while offering ideal physical properties for the retention of temporary crowns and bridges.

Provicol QM Aesthetic from VOCO

VOCO America introduced its latest temporary cement, Provicol QM Aesthetic which is designed to secure provisional crowns and bridges without negatively impacting the color of the temporary restoration.

The cement is a zinc oxide-based, transparent, non-eugenol material that reportedly promotes antibacterial properties while providing the adhesion and strength required when seating temporary restorations. The cement is formulated for easy cleanup and does not bond to composite core build-ups.

The material achieves its translucency by employing a novel glass matrix with polyhedral particles. The material is highly radiopaque, has a low film thickness, and contains calcium hydroxide which can promote the development of tertiary dentin while helping to prevent hypersensitivity.

Provicol QM Aesthetic is available in 5 ml QuickMix automix syringes.

Recent Videos
DS World 2024 Interview with Dentsply Sirona President and CEO Simon Campion in Las Vegas.
Greg Campbell, DDS, talks about the next generation zirconia blocks from Kuraray at DS World in Las Vegas.
At DS World 24, Max Milz, Dentsply Sirona VP, Connected Technology Solutions, talks about the company's new Primescan 2 intraoral scanning solution and how it fits in with a variety of digital dentistry workflows.
CDA 2024 Video Interview with Kuraray Noritake's Dinesh Weerasinghe and Richard Young, DDS
2024 Dental Products Report Spring Selection Bracket Reveal Video
Addressing Unmet Needs in Early Childhood Oral Care - an interview with Ashlet Lerman, DDS
2024 Chicago Dental Society Midwinter Meeting – Interview with Peter Maroon, business development and sales lead at Spectrum Solutions® on the new salivary diagnostic test, SimplyPERIO.
CDS 2024: Ivoclar's e.max ZirCAD Prime Blocks with Shashi Singhal, BDS, MS
© 2024 MJH Life Sciences

All rights reserved.